NOTCH1 and neoplasm: In this study, the effects of resveratrol and Notch-1 on tumor tissue and the tolerances of persons taking resveratrol for up to three months with neuroendocrine tumors (5 g a day, administered orally in two doses of 2.5 g each, with a minimal limiting dose according to the standard toxicity criteria of the National Cancer Institute) were investigated.